{"filing":{"accession_number":"0001213900-26-066364","cik":"0001704287","ticker":"BJDX","company_name":"Bluejay Diagnostics, Inc.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"ea0293390-8k_bluejay.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026066364/ea0293390-8k_bluejay.htm"},"events":[{"id":6263,"run_id":5490,"accession_number":"0001213900-26-066364","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Bluejay Diagnostics completed a private placement on June 5, 2026, issuing pre-funded warrants, Series G warrants, and Series H warrants to purchase up to 10,967,751 shares of common stock for approximately $7.7 million in gross proceeds to accredited investors under Section 4(a)(2) and Rule 506.","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5337,"accession_number":"0001213900-26-066364","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Bluejay Diagnostics entered into a private placement on June 2, 2026, selling pre-funded warrants, Series G warrants, and Series H warrants to purchase up to 10,967,751 shares of common stock (3,655,917 shares × 3 warrant types) for approximately $7.7 million in gross proceeds. This is a classic dilutive equity issuance—unregistered securities sold to accredited investors under Section 4(a)(2) and Rule 506, with substantial warrant overhang that will dilute existing shareholders upon exercise. The transaction is material to investors assessing the company's capital structure and shareholder dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T21:16:13.356695+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5338,"accession_number":"0001213900-26-066364","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 explicitly addresses \"Unregistered Sales of Equity Securities,\" which is the defining characteristic of a dilutive issuance. The incorporation by reference to Item 1.01 (a material contract or plan adoption item) suggests a structured equity transaction. Unregistered equity sales are material to investors as they signal capital raising and shareholder dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T21:16:13.356695+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5339,"accession_number":"0001213900-26-066364","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a private placement that was priced on June 2, 2026 and closed on June 5, 2026. Private placements of equity securities are dilutive issuances under Item 3.02 (or disclosed under Item 8.01 as here), and represent a material capital-raising event that would affect investor assessment of share dilution and the company's financial position. The attached press releases provide the specific terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T21:16:13.356695+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5337,"accession_number":"0001213900-26-066364","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Bluejay Diagnostics entered into a private placement on June 2, 2026, selling pre-funded warrants, Series G warrants, and Series H warrants to purchase up to 10,967,751 shares of common stock (3,655,917 shares × 3 warrant types) for approximately $7.7 million in gross proceeds. This is a classic dilutive equity issuance—unregistered securities sold to accredited investors under Section 4(a)(2) and Rule 506, with substantial warrant overhang that will dilute existing shareholders upon exercise. The transaction is material to investors assessing the company's capital structure and shareholder dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T21:16:13.356695+00:00","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-08"},{"id":5338,"accession_number":"0001213900-26-066364","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 explicitly addresses \"Unregistered Sales of Equity Securities,\" which is the defining characteristic of a dilutive issuance. The incorporation by reference to Item 1.01 (a material contract or plan adoption item) suggests a structured equity transaction. Unregistered equity sales are material to investors as they signal capital raising and shareholder dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T21:16:13.356695+00:00","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-08"},{"id":5339,"accession_number":"0001213900-26-066364","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a private placement that was priced on June 2, 2026 and closed on June 5, 2026. Private placements of equity securities are dilutive issuances under Item 3.02 (or disclosed under Item 8.01 as here), and represent a material capital-raising event that would affect investor assessment of share dilution and the company's financial position. The attached press releases provide the specific terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T21:16:13.356695+00:00","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-08"}]}